New Rules Discovered for Effective CRISPR Activation

Scientists from the Wellcome Sanger Institute and other collaborators have discovered new rules for using CRISPR activation technology effectively. CRISPR activation (CRISPRa) is a technique used to overexpress certain genes, but predicting its efficiency when aimed at specific points in the genome can be challenging. To investigate what features influence how well CRISPRa works for different sets of genes, the researchers used human stem cells and neurons. They integrated a marker gene at thousands of points in the genome of a human stem cell line, which was then activated with CRISPRa, to see where this was successful. The stem cell line used differentiates into neurons, allowing the team also to gather information on CRISPRa efficiency in different cell types.

The study, published in Molecular Cell, uncovered multiple features that impact CRISPRa efficiency, including expression level, chromatin status, cell state, and gene location. They found that bivalent genes, which are key developmental regulator genes that have both repressing and activating marks in the same region, can be robustly activated by CRISPRa. They also discovered that CRISPRa could achieve the same overexpression levels necessary to drive significant changes in cell state and cause them to differentiate.

While most genes can be activated by CRISPRa, the team noted that not every cell responded to the same extent. For example, genes containing H3K9me3 repressing regulators, and therefore are shielded from activation, showed more significant variation in response. These data demonstrate for the first time that CRISPRa is generally applicable across chromatin states and cell types, and highlights the factors that impact the degree of gene activation and how easy it is to reproduce the effects. Understanding these factors is important in designing and analyzing CRISPRa screens, which are used to look for genes involved in genetic diseases.

Dr. Qianxin Wu, first author from the Wellcome Sanger Institute, says, "Our research has established a system for reporting the effectiveness of CRISPR activation in stem cells, allowing us to gain a better understanding of how CRISPRa works in multiple cell states. We also showed that CRISPR gene activation is powerful enough to induce stem cells to differentiate into other cell states. This suggests that CRISPRa screens can be used to search for genes involved in cellular processes or to generate more accurate models of cell types in the body, aiding research into genetic diseases and regenerative medicine."

Dr. Andrew Bassett, senior author from the Wellcome Sanger Institute, adds, "CRISPR activation is a widely used, and incredibly valuable technique when it comes to genome editing, and our research aims to support those using it and help them get the most out of their experiments. By investigating the factors that impact CRISPRa efficiency in a systematic way, we have created a set of rules that show where it is most or least effective and deepened our understanding of the factors involved."

These findings offer a significant step forward in our overall understanding of CRISPR activation technology. By providing a set of rules that show where CRISPRa is most or least effective, the study supports scientists using CRISPRa and helps them get the most out of their experiments. The research also sheds light on the potential of CRISPRa screens in searching for genes involved in cellular processes and generating more accurate models of cell types in the body. Further research is required to continue to add to these rules and to see whether different CRISPRa or CRISPR interference techniques behave similarly.